The retained expression of CD16 and even upregulated expression of NKp46 on CTCL skin NK cells opens up for using trifunctional NK cells engagers targeting CD16, NKp46 and tumor antigen to elicit anti-tumor responses by NK cells (32). This evidence concerns the gene NCR1 and neoplasm.